S-8

Registration No. 333-_______

                   SECURITIES AND EXCHANGE COMMISSION
                        WASHINGTON, D.C.  20549
                             ______________

                              FORM S-8
                       REGISTRATION STATEMENT
                               UNDER
                     THE SECURITIES ACT OF 1933
                        _____________________

              CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT, INC.
         (Exact name of registrant as specified in its charter)

         Florida                                    59-3029743
(State or other jurisdiction of         (I.R.S. Employer Identification No.)
 incorporation or organization)

3713 S.W. 42nd Avenue. Suite 3, Gainesville, Florida      32608-6581
     (Address of principal executive office)              (Zip Code)

                        Bruce Brashear, Esq.
                    920 N.W. 8th Avenue, Suite A
                     Gainesville, Florida 32601
                           (352) 336-0800
           (Name, address and telephone number, including 
                  area code, of agent for service)
                           _______________

              Consultation for Video Production 
                       (Full Title of the Plan)
                           _______________




                 CALCULATION OF REGISTRATION FEE

                                             
   Title           Amount to be   Proposed maximum    Proposed maximum        Amount of
of Securities       registered     offering price    aggregate offering    Registration fee
                                     per share      price 
Common Stock, 
par value $.0001      10,000            $1.0625             $10,625               $5.00


 The price stated above is estimated solely for the purpose of calculation
 of registration fee and is based on the average of the high and low prices 
paid for a share of the Company's Common Stock on April 29, 1997.





PART I

Item 1.     Plan Information


Consulting Services Agreements

     The Video Production Reservation dated May 22, 1997, between 
Cyclodextrin Technologies Development, Inc. (the "Company") and 
Atlantic Syndication Network, Inc.(the "Consultant") requires the 
Company to pay Consultant 10,000 shares of the Company's Common Stock as 
partial compensation for video production services.  Under the terms of the 
Video Production Reservation, Consultant has agreed to provide five (5) five 
video interviews and to air those interviews.  The Common 
Shares are fully vested at the time of issuance.

Item 2.     Registrant Information and Employee Plan Annual Information

     Plan participants may obtain, without charge, upon written or oral 
request, any of the documents incorporated by reference in Item 3 of Part II 
of this Registration Statement; these documents are incorporated by reference 
in the Section 10(a) prospectus which is a part of this Registration 
Statement.  Plan participants may also obtain, without charge, upon written or 
oral request, any other documents required to be delivered to employees 
pursuant to Rule 428(b).  All requests for documents should be directed to:  
Cyclodextrin Technologies Development, Inc., Attention: President, 3713 S.W. 
42nd Avenue, Suite 3, Gainesville, FL 32608-6581; telephone 352-375-6822.

PART II

Item 3.     Incorporation of Documents by Reference

The following documents are incorporated by reference into this Registration 
Statement, and are made a part hereof:

(a)     The Registrant's latest annual report for the year ended December 31, 
1996, on Form 10-KSB filed on or about March 28, 1997.

(b)     All other reports filed by the registrant pursuant to Section 13(a) or 
15(d) of the Exchange Act since the end of the fiscal year covered by the Form 
10-KSB referred to in paragraph (a) above.

(c)     The descriptions of the registrant's securities which are contained in 
its registration statements filed under section 12 of the Securities Exchange 
Act of 1934, including any amendment or reports filed for the purpose of 
updating such descriptions.

All reports filed by the Registrant pursuant to Section 13(a), 13(c), 14 and 
15(d) of the Securities Exchange Act of 1934, after the date of this 
Registration Statement and prior to the filing of a post-effective amendment 
indicating that all of the securities offered hereby have been sold, or 
deregistering all such securities then remaining unsold, shall be deemed to be 
incorporated by reference and to be a part hereof from the date of filing of 
such documents.  Any statement contained in a document incorporated or deemed 
to be incorporated by reference herein shall be deemed to be modified or 
superseded for purposes of this Registration Statement to the extent that a 
statement contained herein or in any other subsequently filed document which 
also is incorporated or deemed incorporated by reference herein modifies or 
supersedes such statement.  Any such document so modified or superseded shall 
not be deemed, except as so modified or superseded, to constitute a part of 
this Registration Statement.

Item 4.     Description of Securities.

Not Applicable.

Item 5.     Interests of Named Experts and Counsel.

Not Applicable.

Item 6.     Indemnification of Officers and Directors.

     The By-Laws of the Company, contain a provision under which the officers 
and directors of the Company would be indemnified to the full extent permitted 
by law. Also, Sec. 607.0850, Fla. Stat. (1995), permits indemnification against
expenses actually and reasonably incurred by a director, officer, employee or 
agent to the extent that such person has been successful in the defense of a 
matter eligible for indemnification under the statute. Under certain 
circumstances, expenses may be paid by a corporation in advance, subject to 
repayment, unless the defendant ultimately is determined to be ineligible for 
indemnification. In addition, the statute permits a corporation to indemnify 
directors and officers against certain liabilities and to purchase and 
maintain director and officer liability and reimbursement insurance against 
liabilities, whether or not the corporation would have the power of 
indemnification against such liabilities.

Item 7.     Exemption from Registration Claimed.

Not Applicable.

Item 8.     Exhibits.
                                                                          Page
     (4)  Instruments defining the rights of security holders,
          including indentures
          (a)  Video Production Reservation between
               Cyclodextrin Technologies Development, Inc. 
               and Atlantic Syndication Network, Inc.
               dated May 22, 1997     

     (5)  Opinion re legality     
     (15) Letter re unaudited interim financial information               None
     (24) Consents of experts and counsel
          (a)  Consent of James Moore & Co. , L.P.   
          (b)  Davis, Monk & Company
          (c)  Consent of Bruce Brashear, Esq.     

     (28) Additional exhibits                                             None
     (29) Information from reports furnished to state insurance 
          regulatory authorities                                          None



Item 9.     Undertakings.

     (a) The undersigned registrant hereby undertakes:

          (1) To file, during any period in which it offers or sells 
securities, a post-effective amendment to this registration statement to 
include any additional or changed material information on the plan of 
distribution.

          (2) That, for the purpose of determining any liability under the 
Securities Act of 1933 treat each post-effective amendment as a new 
registration statement of the securities offered, and the offering of the 
securities at that time to be the initial bona fide offering.

          (3) File a post-effective amendment to remove any of the securities 
that remain unsold at the end of the offering.

     (b) The undersigned registrant hereby undertakes that, for the purposes 
of determining any liability under the Securities Act of 1933, each filing of 
the registrant's annual report pursuant to section 13(a) or section 15(d) of 
the Securities Exchange Act of 1934 (and, where applicable, each filing of an 
employee benefit plan's annual report pursuant to section 15(d) of the 
Securities Exchange Act of 1934) that is incorporated by reference in the 
registration statement shall be deemed to be a new registration statement 
relating to the securities offered therein, and the offering of such 
securities at that time shall be deemed to be the initial bona fide offering 
thereof.

     (h) Insofar as indemnification for liabilities arising under the 
Securities Act of 1933, as amended (the "Act"), may be permitted to directors, 
officers and controlling persons of the registrant pursuant to the foregoing 
provisions, or otherwise, the registrant has been advised that in the opinion 
of the Securities and Exchange Commission such indemnification is against 
public policy as expressed in the Act and is, therefore, unenforceable.  In 
the event a claim for indemnification against such liabilities (other than the 
payment by the registrant of expenses incurred or paid by a director, officer 
or controlling person of the registrant the successful defense of any action, 
suit or proceeding) is asserted by such director, officer or controlling 
person in connection with the securities being registered, the registrant 
will, unless in the opinion of its counsel the matter has been settled by 
controlling precedent, submit to a court of appropriate jurisdiction the 
question whether such indemnification by it is against public policy as 
expressed in the Act and will be governed by the final adjudication of such 
issue.



                                 SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, as amended, 
the registrant certifies it has reasonable grounds to believe it meets all the 
requirements for filing on Form S-8 and has duly caused same to be signed on 
its behalf by the undersigned, thereunto duly authorized, in the City of 
Gainesville, State of Florida, on the 9th day of May, 1997. 


                    Cyclodextrin Technologies Development, Inc.


                    By:  __/s/ C.E. Rick Strattan____________
                           C.E. Rick Strattan,
                           President and Chief Executive Officer, 
                           Chairman of the Board, 


     KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears 
below constitutes and appoints C.E. Rick Strattan his true and lawful 
attorney-in-fact and agent with full power of substitution and resubstitution 
for him and in his name, place and stead, in any and all capacities, to sign 
any and all amendments (including post-effective amendments) to this 
Registration Statement, and to file the same, with all exhibits hereto, and 
other documents in connection therewith, with the Securities and Exchange 
Commission, granting unto said attorney-in-fact and agent full power and 
authority to do and perform each and every act and thing requisite and 
necessary to be done on or about the premises, as fully and for all intents 
and purposes as he might or could do in person, hereby ratifying and 
confirming all that said attorney-in-fact and agent, or his substitute or 
substitutes, may lawfully do or cause to be done by virtue hereof.

     Pursuant to the requirements of the Securities Act of 1933, as amended, 
this Registration Statement has been signed by the following persons in the 
capacities indicated, on the dates indicated.

     Signature                         Title


_/s/ C. E. RICK STRATTAN _________       Chairman of the Board, President, CEO
C. E. RICK STRATTAN

Date: May 9, 1997

EX-4

Video Production Reservation

Cyclodextrin Technologies Development, Inc.
3713 S.W. 42nd Avenue
Gainesville, FL 32608-6581
Phone:  (352) 375-6822
Fax:  (352) 375-8287

C.E. Rick Strattan, CEO/President

	Corporation (GUEST) hereby requests Atlantic Syndication 
Network, Inc. (PRODUCER) to reserve the production time 
identified herein to produce an interview segment with the 
Guest company which will be edited into a (5) five-minute 
segment and then scheduled to air on The Stock ShowTM in the 
regions(s) agreed to by the parties.

Regions of interest include:  Northeast and Southeast (to be 
defined)

Videotaping of the interview is scheduled to take place in 
Hollywood, California on the following date(s) May 23.  Each 
featured Guest will receive an itinerary 15 days prior to the 
actual date of production.

Guest agrees to provide within 15 days any logos, charts, 
displays, slides and/or videotape, etc. to be used during the 
production of their segment.  It's understood that any 
expenses required for travel, hotel and ground transportation 
are the responsibility of each Guest.

Guest herein represents that it is not under any existing or 
pending SEC rulings to jeopardize the integrity of the show 
and agrees to provide the producer with its current SEC 
filings and any other requested regulatory documents.

This reservation deposit in the amount of $2,500.00 is non-
refundable and will initiate the scheduling of a specific 
time period for production of the subject video.  Each party 
agrees to complete its respective responsibilities in 
preparation for the video production as identified herein.  
This deposit will be applied to Guest production charges of 
approximately $________________ (Plan ____________)  The 
exact amount due for production will be identified in the 
Guest Production Agreement.  Optional charges for videotape 
copies or additional services will be billed separately.

In the event Guest does not comply with the requirements and 
conditions of this Agreement, Guest acknowledges that 
Producer retains the right to replace Guest with a substitute 
(another Guest) and this reservation deposit will be 
forfeited.  Any balance or payment due must be paid in full 
prior to June 30 (or) within 30 days of the actual interview 
segment videotaping.  ANY EXCEPTION TO THIS REQUIREMENT must 
be in writing and approved by the Producer and the Executive 
in Charge of Production.

THIS RESERVATION IS VALID ONLY WHEN ACCOMPANIED BY PAYMENT 
AND APPROVED BY THE GUEST CORPORATION AND ASNI.

Other conditions:  See attached letter.

Corporation:  CTD, Inc.
Mr. Kent Wyatt
Atlantic Syndication Network, Inc.
6363 Sunset Blvd., Suite 910
Hollywood, CA 90028

Dear Kent:

	Find enclosed the completed and signed reservation 
form with the deposit check for $2,500.  

	This letter is intended to form a part of the above 
reservation form for the purpose of stating the agreed 
financial terms we agreed upon:

		(1)	On or before May 9, 1997, CTD will 
provide ASNI with 10,000 freely trading shares of CTD's 
non-voting common stock.
		(2)	On or before June 30, 1997, CTD will 
provide documents granting ASNI the option to purchase 
25,000 shares of CTD's non-voting common stock at $1.00 
per share.

	I am grateful for the opportunity to bring the 
story of cyclodextrins to the investing public.  
Cyclodextrins promise to make drug therapy more patient-
friendly and hazardous waste treatment more nature-
friendly.

	I look forward to working with you.

						Sincerely,



						Rick Strattan

EX-5

May 9, 1997





Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549


	RE:	Registration Statement on Form S-8
		Cyclodextrin Technologies Development, Inc.
		

Gentlemen:

	I have acted as counsel for Cyclodextrin Technologies Development, Inc. 
(the "Company") in connection with its proposed offering 
to Atlantic Syndication Network, Inc. a consultant of the Company 
of 10,000 common shares(par value $.0001).  In connection with the proposed
public offering and above-described registration statement, I have reviewed 
the following:

	1. The Certificate of Incorporation and amendments thereto of the Company;

	2. The By-Laws and amendments thereto of the Company;

	3. The minute books of the Company; and

	On the basis of such investigation and the examination of such other 
records as I deemed necessary, I am of the opinion that:

	a) the Company has been duly incorporated and is validly existing under 
the laws of the State of Florida; and

	b) The 10,000 shares have been duly authorized and when issued, will be 
legally issued by the Company and will be fully paid and nonassessable.

	I consent to the filing of this opinion as an Exhibit for the purpose of 
registering all or a portion of the Common Shares described in 
Form S-8 under the relevant state and federal 
securities laws.



						Sincerely,


						/s/ Bruce Brashear
						Bruce Brashear, Esq.

EX-23

CONSENT OF INDEPENDENT
CERTIFIED PUBLIC ACCOUNTANTS

Cyclodextrin Technologies Development, Inc.


We hereby consent to the incorporation by reference on the Registration 
Statement on Form S-8 of our report dated February 5, 1996, included in 
the Form 10KSB of Cyclodextrin Technologies Development, Inc. for the 
year ended December 31, 1995.


							/s/ James Moore & Co., L.P.
							James Moore & Co., L.P.

Gainesville, Florida
May 9, 1997

EX-23

CONSENT OF INDEPENDENT
CERTIFIED PUBLIC ACCOUNTANTS

Cyclodextrin Technologies Development, Inc.


We hereby consent to the incorporation by reference on the Registration 
Statement on Form S-8 of our report dated February 21, 1997, included in 
the Form 10KSB of Cyclodextrin Technologies Development, Inc. for the 
year ended December 31, 1996.


							/s/ Davis, Monk & Company
							Davis, Monk & Company


Gainesville, Florida
May 9, 1997